ESMO Daily Reporter
The ESMO Daily Reporter is the official ESMO newspaper providing live reporting, highlights, critical insights on data presented at ESMO congresses, and expert opinions on controversial topics.
Newsroom
Read the latest news and updates from ESMO and the oncology community
Resources for Press Representatives
For press representatives interested in reporting on cancer issues, check for the latest press releases and press briefings, abstract announcements, embargo policies, meeting information and tailored resources.
Society Updates
ESMO Welcomes Confirmatory Hearings Outcomes for Commissioner-Designate Olivér Várhelyi
ESMO welcomes the outcome of the hearings for Olivér Várhelyi, Commissioner-designate for Health and Animal Welfare, where several topics relevant for the oncology community were addressed in a positive or at least promising way
ESMO Award for Immuno-Oncology 2024 Recipient Announced
The ESMO Award for Immuno-Oncology 2024 is presented to Ton N. Schumacher in recognition of his exceptional contributions to cancer immunology and to our understanding of the mechanism of how immunotherapy works
Oncology News
Contact X-ray Brachytherapy Dose Escalation Increases the Organ Preservation Rate in Patients with Small, Early-Stage Rectal Cancer
Findings from the OPERA study
Inavolisib Plus Palbociclib–Fulvestrant Prolongs PFS in Patients with PIK3CA-mutated, HR-positive, HER2-negative Advanced Breast Cancer
Findings from the INAVO120 study
EMA Recommends Granting a Conditional Marketing Authorisation for Repotrectinib
It is intended for the treatment of patients with solid tumours with NTRK gene fusion and patients with ROS1-positive advanced NSCLC